Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03664674 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
A Phase 3 study, sponsored by Otonomy.
- Completed
- Registry status
- Phase 3
- Development phase
- 148
- Enrollment target
NCT03664674 is a Phase 3 study that has completed, run by Otonomy. The registered enrollment target is 148 participants.
The verdict
NCT03664674, a Phase 3 study, has completed, sponsored by Otonomy.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
Interventions
- DRUG Placebo
- DRUG OTO-104
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2020-12-22 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03664674
The ClinicalTrials.gov registry entry for NCT03664674 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otonomy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03664674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03664674 about?
NCT03664674 is a clinical study titled "Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease". The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
What is the current status of trial NCT03664674?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 148 participants. The study started on 2018-08-27. Estimated completion is 2020-12-22.
What interventions are being tested in trial NCT03664674?
The interventions under investigation include: Placebo (DRUG), OTO-104 (DRUG).
Who is sponsoring clinical trial NCT03664674?
This trial is sponsored by Otonomy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.